Cargando…
Transition of maternal serum concentration of digoxin and flecainide in the third trimester—A case report of fetal supraventricular tachycardia with hydrops
When transplacental therapy is conducted, the maternal serum concentrations of digoxin and flecainide may fluctuate throughout third trimester. Therefore, TDM may be effective in improving the efficacy and safety of treatment.
Autores principales: | Takatsuka, Hirokazu, Wakabayashi, Kayo, Yamazaki, Shingo, Tanaka, Hirokazu, Omoto, Akiko, Suzuki, Takaaki, Shozu, Makio, Ishii, Itsuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117821/ https://www.ncbi.nlm.nih.gov/pubmed/34026129 http://dx.doi.org/10.1002/ccr3.3992 |
Ejemplares similares
-
Resolution of Fetal Hydrops Dependent on Sustained Fetal Supraventricular Tachycardia after Digoxin Therapy
por: Maciuleviciute, Aureja, et al.
Publicado: (2020) -
Flecainide intoxication in pediatric patients with supraventricular tachycardia
por: Vaquer, Guiem, et al.
Publicado: (2020) -
Fetal Intervention for Refractory Supraventricular Tachycardia Complicated by Hydrops Fetalis
por: Munoz, Jessian L., et al.
Publicado: (2022) -
Successful medical treatment of fetal supraventricular tachycardia that cause hydrops fetalis
por: Çetin, Cihan, et al.
Publicado: (2014) -
Multiple direct fetal amiodarone administration for supraventricular tachycardia with hydrops fetalis: a case report
por: Adenin, Irvan, et al.
Publicado: (2023)